FDA Approves Vadadustat for Oral Treatment of Anemia Due to Chronic Kidney Disease
Vadadustat (Vafseo; Akebia Therapeutics Inc) is indicated for individuals with chronic kidney disease who have been receiving dialysis for at least 3 months.
Source: pharmacytimes.com